...
首页> 外文期刊>Emerging Infectious Diseases >Hemolytic Uremic Syndrome
【24h】

Hemolytic Uremic Syndrome

机译:溶血性尿毒症综合征

获取原文

摘要

Along with a report of the first outbreak of hemolytic uremic syndrome (HUS) caused by Shiga-like toxin (SLT) producing E. coli in Australia (1), this issue of Emerging Infectious Diseases presents three papers detailing the investigations of pediatric HUS cases linked to Shiga toxin (ST) and SLT producing bacteria. Goldwater and Bettelheim present a case of pediatric HUS associated with SLT producing Escherichia coli (SLTEC) O48:H21 in South Australia; this strain has not previously been recognized as an SLTEC. Saeed et al. report on the increasingly common identification of HUS in Saudi Arabia, its association with multiple-antibiotic-resistant Shigella dysenteriae type 1, and the inherent dangers of treating such patients with ampicillin and nalidixic acid. Al- Qawari et al. report on the results of active surveillance for dysentery and HUS in Saudi Arabia and discuss a possibly elevated risk for HUS in patients with bloody diarrhea who are hospitalized and treated with nalidixic acid during an outbreak of S. dysenteriae type 1.
机译:在澳大利亚首次报告了由产生志贺氏样毒素(SLT)的大肠杆菌引起的溶血性尿毒综合症(HUS)的首次爆发(1),此期《新兴传染病》提供了三篇论文,详细介绍了小儿HUS病例的调查与志贺毒素(ST)和SLT产生细菌有关。 Goldwater和Bettelheim在南澳大利亚展示了一例与SLT产生的大肠杆菌O48:H21相关的小儿HUS病例。该菌株以前未被认为是SLTEC。 Saeed等。关于HUS在沙特阿拉伯越来越普遍的鉴定,其与多重抗药性痢疾痢疾志贺氏菌的关联以及使用氨苄西林和萘啶酸治疗此类患者的固有危险性的报告。 Al-Qawari等。报告沙特阿拉伯痢疾和HUS的积极监测结果,并讨论在1型痢疾链球菌暴发期间住院并接受萘啶酸治疗的血性腹泻患者的HUS风险可能升高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号